Skip to main content

Advertisement

SpringerLink
Log in

Letter: The Importance of Complete Pathologic Response after Neoadjuvant Systemic Treatment in Breast Cancer Research and Practice

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Al Mushawah F, Tan MC, Margenthaler JA (2009) Residual nodal disease in biopsy proven N1/N2 breast cancer following neoadjuvant systemic therapy. World J Surg 34:256–260

    Article  Google Scholar 

  2. Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995

    Article  CAS  PubMed  Google Scholar 

  3. Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360:1362; author reply 1363

    Article  CAS  PubMed  Google Scholar 

  4. Roukos DH (2009) Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol 27:1337–1338

    Article  PubMed  Google Scholar 

  5. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249:1067–1068

    Article  PubMed  Google Scholar 

  6. Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9(3):227–229

    Article  PubMed  Google Scholar 

  7. Roukos DH (2009) Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther 9(4):389–392

    Article  PubMed  Google Scholar 

  8. Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16(3):774–775

    Article  PubMed  Google Scholar 

  9. Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128

    Article  CAS  PubMed  Google Scholar 

  10. Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48

    Article  CAS  PubMed  Google Scholar 

  11. Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenictherapy in cancer. Expert Rev Anticancer Ther 9(10):1413–1416

    Article  PubMed  Google Scholar 

  12. Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771–1782

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery (B’ Unit), “METAXA” Cancer Memorial Hospital, Piraeus, Greece

    K. Kalogerakos

Authors
  1. K. Kalogerakos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Kalogerakos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalogerakos, K. Letter: The Importance of Complete Pathologic Response after Neoadjuvant Systemic Treatment in Breast Cancer Research and Practice. World J Surg 34, 1984–1985 (2010). https://doi.org/10.1007/s00268-010-0496-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-010-0496-2

Keywords

Search

Navigation